Norton Rose Fulbright has advised Citic Securities and HSBC on the deal. Lepu Biopharma Co., Ltd, a biopharmaceutical company, has completed the placing of new shares on...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here